MedTrace Logo

Intestinal Microbiota in Stem Cell Transplant Transplant Admission

NCT04623424 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 255

Last updated 2026-02-24

No results posted yet for this study

Summary

In this prospective study, the primary objective will be to investigate the association between the use of antibiotics administered during the admission period of Stem cell transplant (SCT) and the rate of overall change in microbiota composition across adjacent samples in time.

Conditions

  • Stem Cell Transplant Complications

Interventions

DIAGNOSTIC_TEST

intestinal microbiota

Stoll samples will be tested for different bacteria

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • shatha farhan · Henry Ford

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-03
Primary Completion
2028-11-03
Completion
2028-11-03

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04623424 on ClinicalTrials.gov